HEALTH PROFESSIONAL · SOURCE READING

Postmenopausal women

Source: Breast Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 25, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Systemic Therapy for Stages I, II, and III Breast Cancer / Stages I, II, and III HER2-Negative Hormone Receptor–Positive Breast Cancer / Aromatase inhibitors

In postmenopausal women, the use of AIs in sequence with or as a substitute for tamoxifen has been the subject of multiple studies, the results of which have been summarized in an individual patient-level meta-analysis.[60]

Source links and citations

Continue within this section

Initial therapy →

Publication references

Read the original reference and check its publication notices.

PubMed 26211827 · Original source

Preserved source evidence · Not medical advice